Type 2 diabetes with heart failure and CKD — RCPSC IM MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Add an SGLT2 inhibitor with cardiorenal benefit
SGLT2 inhibitors reduce heart failure and kidney outcomes in type 2 diabetes with HFrEF and CKD when eGFR allows use.
Reference: Diabetes Canada 2024 pharmacologic glycemic management update